CoreValve ADVANCE Study
ADVANCE is a rigorous, fully monitored study of TAVI in the "real world." 1,015 patients intended to be treated with the Medtronic CoreValve System were enrolled at 44 centers (in 12 countries worldwide).
- All ECGs and procedural angiograms were assessed by a core lab.
- All primary endpoints were adjudicated by an independent Clinical Event Committee.
- All cerebrovascular events were adjudicated by an independent neurologist.
Clinical endpoints reported according to Valve Academic Research Consortium (VARC).